Production of recombinant HPV11/16 E6/E7-MBP-His6 fusion proteins and their potential to induce cytokine secretion by immune cells in peripheral blood.

Human papillomavirus (HPV) infection poses a significant threat to public health worldwide. Targeting the function of HPV E6 and E7 proteins and activating the host immune response against these proteins represent promising therapeutic strategies for combating HPV-related diseases. Consequently, the efficient production of soluble, high-purity E6 and E7 proteins is crucial for function and host immune response studies. In this context, we selected the pMCSG19 protein expression vector for Escherichia coli to produce soluble MBP-His6 tagged HPV11/16 E6/E7 proteins, achieving relatively high purity and yield. Notably, these proteins exhibited low toxicity to peripheral blood mononuclear cells (PBMCs) and did not compromise their viability. Additionally, the recombinant proteins were capable of inducing the secretion of multiple cytokines by immune cells in peripheral blood, indicating their potential to elicit immune responses. In conclusion, our study offers a novel approach for the production of HPV11/16 E6/E7 fusion proteins with relatively high purity and yield. The fusing HPV11/16 E6/E7 proteins to MBP-His6 tag may serve as a valuable method for large-scale protein production in future research endeavors.

Chemical Constituents of the Marine Fungus Penicillium sp. MCCC 3A00228.

One new (d-arabinitol-anofinicate, 1) and fourteen known (2-15) compounds were isolated from the marine Penicillium sp. MCCC 3A00228. The structure of the new compound was established mainly by extensive spectroscopic analyses. Compound 1 exhibited weak transcriptional effect on Nur77. While compound 13 showed moderate in vitro anti-proliferative effect against QGY7701, H1299, and HCT116 tumor cells with IC50 values of 21.2 µM, 18.2 µM, and 17.6 µM, respectively.

[Pharmacognostical study on four origin plants of folk medicine Sikuaiwa].

In order to develop characteristic folk medicine resources in Jiangxi, a pharmacognostical study was systematically performed for four different origin plants of Sikuaiwa, the result of study provides the microscopic features of powder and tissue of the crude drug. The research provided reference for the identification of Sikuaiwa, as well as a theoretical basis for the further development and the formulation of quality standards.

[Study on the interaction of levofloxacin and MCM-41 by fluorescence spectrum].

The mesoporous molecular sieve MCM-41 was synthesized by hydrothermal method under microwave irradiation and the levofloxacin was encapsulated in the hexagonal ordered channels of MCM-41 using pickling process. The structure and property of MCM-41 and LVFX/MCM-41 were characterized by means of small-angle X-ray diffraction(XRD), Fourier transform infrared spectroscopy (FTIR), N2 physical adsorption, and thermogravimetric analysis-differential thermal analysis (TGA-DTA). The pore diameter and the specific surface area of the mesoporous molecular sieve MCM-41 synthesized under microwave irradiation were 2.382 nm and 1015 m2 x g(-1) respectively. The fluorescence spectra of MCM-41, LVFX/MCM-41, LVFX (solid) and LVFX (solution) were investigated. The results indicated that there were some visible red shifts in the fluorescence spectrum of the composite of LVFX/MCM-41 as compared with the samples before being encapsulated. It was inferred from the results that hydrogen bonds were formed between levofloxacin and the hydroxy group in the inner pores, and the electron cloud could transfer from the hydroxy group to electro-attracting group. At the same time, the electron cloud could transfer in much larger annulations, and the conjugated system of LVFX was extended because of the new annulations formed, which contributed to the red shifts of the fluorescence spectra. The strong interactions between the LVFX and MCM-41 provided the theory for developing a novel delayed release drug using MCM-41 as the carriers.